Lonza
Lonza is a Swiss pharma and biotech CDMO that co-established the Prolog Lonza Consumer Fund to invest in North American consumer health and wellness startups.
Lonza is headquartered in Basel, Switzerland, has 1 recorded investment, and includes 1 company in its recorded portfolio.
- Headquarters
- Basel, Switzerland
- Website
- lonza.com
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- May 2021
- Geographic Focus
- North America, United States
Indexed holds 1 portfolio company and 1 funding round for this investor. The full record is or through the API.
Investment Thesis
Lonza is a Venture Capital firm based in Basel, Switzerland. It has made 1 investment, including Affinia Therapeutics. Focus areas include Healthcare and Wellness.
Portfolio1
Co-investors14
Sign up to view co-investors
14 co-investors across 14 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×11 · Hedge Fund ×2 · Corporate VC ×1 · 10 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/lonza"><img src="https://indexed.vc/api/badge/investor/lonza" alt="Lonza on Indexed.vc" width="260" height="76" /></a>